La chirurgie du pontage aorto coronaire chez les diabétiques : Résultats immédiats et à moyen terme

Auteur/ices

  • Habib Ben Ahmed
  • Mehdi Chelli
  • Khalifa Selmi
  • Khaled Bouzouita
  • Imen Hamdi
  • Aida Mokaddem
  • Youssef Ben Ameur
  • Mohamed R Boujnah

Mots-clés :

Pontage aorto coronaire, diabète.

Résumé

Prérequis : Le diabète est classiquement considéré comme un facteur aggravant le pronostic après une chirurgie de pontage aortocoronaire. Des études récentes suggèrent une amélioration du pronostic des coronariens diabétiques bénéficiant d’une revascularisation chirurgicale, néanmoins l’impact direct du diabète sur la morbimortalité reste mal élucidé.
But : Etudier le pronostic à court et à moyen terme des patients diabétiques après une chirurgie de pontage aorto coronaire.
Méthodes : Etude rétrospective ayant intéressé 228 patients revascularisés par pontage aorto coronaire entre 2005 et 2010 et repartis en deux groupes : cent vingt six patients diabétiques et 102 patients non diabétiques. Le groupe de diabétiques comportait plus de femmes (27% Vs 12,7% P=0,009), moins de tabagiques (55,6% Vs 80,4% P<0,0001) et plus de patients tri tronculaires (67,5% Vs 42,2% P=0,005).
Résultats : La mortalité hospitalière était significativement plus élevée chez les diabétiques (16% Vs 4,1% P=0,005) avec un séjour en réanimation plus prolongé (2,3 jours Vs 2,1 jours P=0,048). Le taux de médiastinites post opératoires n'était par contre pas influencé par le diabète (2% Vs 3,2% P=0,69) même en cas d'utilisation de deux artères mammaires.Au bout d'un suivi moyen de 28 mois, la survie des diabétiques était significativement inférieure par rapport au groupe contrôle (91% Vs 99% p<0.001). La survie sans évènements cardiovasculaires majeurs était par contre comparable (76% Vs 80% p=0. 82).
Conclusion : Le diabète aggrave le pronostic immédiat et à moyen terme après une chirurgie de pontage aorto coronaire.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Références

Haffner SM, Lehto S, Rönnemaa T,et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339:229-34.

Wilson PW. Diabetes mellitus and coronary heart disease. Endocrinol Metab Clin North Am. 2001 ;30:857-81.

Woods SE, Noble G, Smith JM, et al. The influence of gender in patients undergoing coronary artery bypass graft surgery: an eight-year prospective hospitalized cohort study. J Am Coll Surg. 2003 ;196:428-34.

Carson JL, Scholz PM, Chen AY, et al . Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002 ;40:418-23.

Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999 ;67:1045-52.

Calafiore AM, Di Mauro M, Di Giammarco G, et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg. 2003 ;125:144-54.

Cohen Y, Raz I, Merin G, Mozes B. Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium. Am J Cardiol. 1998 ;81:7-11.

Woods SE, Smith JM, Sohail S, et al. The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery: an 8-year prospective cohort study. Chest. 2004 ;126:1789-95.

Szabó Z, Håkanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2002; 74:712-19.

Stevens LM, Carrier M, Perrault LP, et al. Influence of diabetes and bilateral internal thoracic artery grafts on long-term outcome for multivessel coronary artery bypass grafting. Eur J Cardiothorac Surg. 2005;27: 281-88.

Serruys PW, Unger F, Sousa JE, et al. Comparison of coronaryartery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117-24.

Antunes PE, de Oliveira JF, Antunes MJ. Risk-prediction for postoperative major morbidity in coronary surgery. Eur J Cardiothorac Surg. 2009; 35:760-66.

Yan BP, Clark DJ, Buxton B, et al. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries. Heart Lung Circ. 2009 ; 18:184-90.

Serruys PW, Morice M-C, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009 ;360:961-72.

Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997 ;96:1761-69.

Farinas JM, Carrier M, Hébert Y, et al. Comparison of long-term clinical results of double versus single internal mammary artery bypass grafting. Ann Thorac Surg. 1999 ;67:466-70.

Endo M, Nishida H, Tomizawa Y, et al. Benefit of bilateral over single internal mammary artery grafts for multiple coronary artery bypass grafting. Circulation. 2001;104:2164-70.

Gansera B, Schmidtler F, Gillrath G, et al. Does bilateral ITA grafting increase perioperative complications? Outcome of 4462 patients with bilateral versus 4204 patients with single ITA bypass. Eur J Cardiothorac Surg. 2006 ;30:318-23.

Nakano J, Okabayashi H, Hanyu M, et al. Risk factors for wound infection after off-pump coronary artery bypass grafting: should bilateral internal thoracic arteries be harvested in patients with diabetes? J. Thorac Cardiovasc Surg. 2008 ;135:540-45.

Douville EC, Asaph JW, Dworkin RJ, et al. Sternal preservation: a better way to treat most sternal wound complications after cardiac surgery. Ann Thorac Surg. 2004 ;78:1659-64.

Hollenbeak CS, Murphy DM, Koenig S, et al. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest. 2000 ;118:397-402.

Bakaeen FG, Chu D, Dhaliwal AS, et al. Does the use of bilateral internal mammary artery grafts impact survival of veterans undergoing coronary artery bypass surgery? Am J Surg. 2008;196:726-31.

Pick AW, Orszulak TA, Anderson BJ, et al. Single versus bilateral internal mammary artery grafts: 10-year outcome analysis. Ann Thorac Surg. 1997;64:599-605.

Hueb W, Gersh BJ, Costa F, et al. Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease. Ann Thorac Surg. 2007 ;83:93-9.

Alserius T, Hammar N, Nordqvist T, et al. Improved survival after coronary artery bypass grafting has not influenced the mortality disadvantage in patients with diabetes mellitus. J Thorac Cardiovasc Surg. 2009 ;138:1115-22.

Hannan EL, Kilburn H, Racz M, et al. Improving the outcomes of coronary artery bypass surgery in New York State. JAMA. 1994 ;271:761-66.

Morris JJ, Smith LR, Jones RH, et al. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation. 1991 ;84:275-84.

Serruys PW, Ong ATL, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005 ;46:575-81.

Téléchargements

Publiée

2012-11-23

Numéro

Rubrique

Articles originaux